Tokyo, July 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062015) titled 'Implementation of Hypertension and Lifestyle Counseling in Community Pharmacies: A Multi-Center Collaborative Quality Improvement (QI) Project for Pharmacist Counseling' on July 1.

Study Type: Observational

Primary Sponsor: Institute - Evergreen Hirojin Co., Ltd.

Condition: Condition - Hypertension, Lifestyle-related diseases Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - The objective of this study is to evaluate the impact of using original patient education materials on pharmacists' awareness of hypertension management, specifically regarding salt reduction, aerobic exercise, moderation in drinking, weight loss, and dietary improvements, as well as on their medication counseling practices (Quality Improvement), while also assessing changes in patients' home blood pressure. Furthermore, to evaluate how pharmacy scale and resource environments (Large, Medium, and Small) affect the implementation and outcomes of this initiative, a stratified analysis by facility size will be conducted. This study ultimately aims to verify the effectiveness and universal reproducibility of QI activities in resource-limited environments. Basic objectives2 - Others

Eligibility: Age-lower limit - 20 years-old <= Age-upper limit - Not applicable Gender - Male and Female Key inclusion criteria - Pharmacy records of patients who meet all of the following criteria will be included:

Adult patients aged 20 years or older.

Diagnosed with hypertension and prescribed antihypertensive medications.

Visited the target pharmacies [on a regular monthly basis (approximately 4-week to 1-month intervals)] during the study period and received medication counseling (intervention) at least once using the original patient education materials.

Capable of or willing to perform morning home blood pressure monitoring at home. Key exclusion criteria - Pharmacy records of patients who meet any of the following criteria will be excluded from the analysis:

Patients who are judged to have extreme difficulty in accurately understanding or implementing medication counseling and home blood pressure monitoring using the original patient education materials due to acute psychiatric illness or worsening dementia.

Patients who are currently participating in other clinical studies or interventional trials that could affect the data extraction of this study.

Other patients deemed inappropriate for data extraction (tracking of pharmacy records) by the attending pharmacist (e.g., transfer to another pharmacy due to relocation, or discontinuation of the intervention during the study period). Target Size - 80

Recruitment Status: Recruitment status - Preinitiation Date of protocol fixation - 2026 Year 04 Month 01 Day Date of IRB - 2026 Year 05 Month 15 Day Anticipated trial start date - 2026 Year 07 Month 01 Day Last follow-up date - 2026 Year 11 Month 01 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070965

Disclaimer: Curated by HT Syndication.